Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Networking, Data Capture Key To Reducing Medical Errors - IEEE Says

This article was originally published in The Gray Sheet

Executive Summary

Medical errors involving certain devices could be reduced by networking systems that incorporate automated safeguards and data capturing technology, a white paper published by the Institute of Electrical and Electronics Engineers (IEEE) suggests.

You may also be interested in...



FDA Device Reviews Need Stronger Patient Safety Criteria - IoM Report

FDA's Center for Devices and Radiological Health should place greater emphasis on patient safety in actual use and real-life settings when approving medical devices, the Institute of Medicine concludes in a report on medical errors, "To Err is Human," released Nov. 30.

Alaris Pump Software Will Facilitate Adoption Of IEEE 1073 Standards

Alaris Medical is planing to make publicly available newly developed software that will facilitate implementation of the Institute of Electrical and Electronics Engineers' 1073 Medical Information Bus (MIB), a new set of standards for medical device communications, the company reported Oct. 12.

Can Organovo Leverage Its Solid Phase II Data In MASH?

Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel